CTSL has become a drug candidate for the SARS-CoV-2pandemic becauseit cleaves the spike protein critical for infection.37 The inhibition of CTSL by chloroquine may also explainthe reported potential beneficial effects of chloroquine in treatingSARS-CoV-2 infection. Here, CTSL is linked to COVID-19.